Home Infusion Therapy Market Share & Size Report, 2028

The home infusion therapy market is expected to grow from US$ 32.45 billion in 2021 to US$ 56.70 billion by 2028, with an estimated CAGR of 8.3% from 2022 to 2028. 

The rapidly growing healthcare industry escalated the development of various home-based healthcare services, including home infusion therapy, representing a vast arena of pharmaceutical services provided in the outpatient setting, typically in the patient’s home. For the treatment of acute and chronic illnesses, infusion medications are administered through a needle or catheter because oral medications are ineffective in treating these diseases. The technological advancements in home care settings have enabled safe and effective administration of medications through infusion; it is also cost-effective as the treatment is provided at home. As a result, home infusion therapy has evolved into a comprehensive medical therapy that is cheaper than inpatient treatment in a hospital or skilled nursing facility. All these parameters have bolstered the home infusion therapy market

MARKET DYNAMICS

The market for home infusion therapy is driven by the growing demand for infusion therapies by the increasing geriatric population with decreased mobility profile, rapid technological advancements, and rising preference for home care. Further, various health conditions such as cardiovascular diseases (CVDs), congestive heart failure, Crohn's disease, and haemophilia require infusion therapy for treatment. Further, immune deficiencies, congestive heart failure, cancer, diabetes, and other life-threatening conditions require long-term treatment. Hence, home infusion therapy is a better cost-effective alternative to hospital treatment.  However, high costs and a dearth of skilled professionals are factors hampering the growth of the market.

MARKET SCOPE

The "Global Home Infusion Therapy Market Analysis to 2028" is a specialized and in-depth study of the market that focuses on the global market trend analysis. The report aims to provide an overview of the market with detailed market segmentation and key statistics on the status of the leading home infusion therapy market players and offers key trends and opportunities in the market.

Strategic Insights

MARKET SEGMENTATION

The global home infusion therapy market is bifurcated into product and application. Based on product, the market is segmented into infusion pumps, ambulatory infusion pumps, intravenous sets, iv cannulas, and needleless connectors. Based on application, the market is segmented into anti-infective, endocrinology, hydration therapy, chemotherapy, enteral nutrition, parental nutrition, specialty pharmaceuticals, and others.

REGIONAL FRAMEWORK

The global home infusion therapy market is segmented into five major regions—North America, Europe, Asia Pacific (APAC), Middle East & Africa (MEA), and South America. The report covers analysis and forecast of 18 countries globally, along with current trends and opportunities prevailing in these regions.

North American dominated the home infusion therapy market in 2021. The market growth is attributed to the presence of many home infusion therapy service providers and product manufacturers. A few of the key players operating in the market across the region include Baxter, BD, and ICU Medical. The below figure showcases the revenue growth trend in the global home infusion therapy market:

Get more information on this report : Request Free Sample PDF

Source: The Insight Partners Analysis

The report analyses factors, such as drivers, restraints, opportunities, and future trends, that impact the home infusion therapy market. It also provides a PEST analysis of the factors affecting the home infusion therapy market across these regions.

IMPACT OF COVID-19 PANDEMIC

The COVID-19 pandemic positively impacted the home infusion therapy market owing to the increasing number of COVID-19 patients in healthcare settings such as hospitals and clinics, which is propelling the use of home infusion therapy systems. The operations and supply chain in the healthcare setting were significantly affected due to the regional and country-wide lockdowns in 2020. Prominent healthcare product manufacturers also reported a rise in product sales in 2020 owing to home care product sales. For instance, in October 2020, Baxter announced third-quarter sales of US$ 2.97 billion, which is a 4% increase in its revenue due to the growing demand for its COVID-19-related medical products.. With the increasing need for space and beds in hospitals during the pandemic, healthcare companies focused on launches of home based care products, thus creating demand for home infusion therapy.

MARKET PLAYERS

The reports cover vital developments in the home infusion therapy market organic and inorganic growth strategies. Various companies are focusing on several organic growth strategies such as product launches, product approvals, patents, and events. Inorganic growth strategy activities witnessed in the market were acquisitions, partnerships, and collaborations. These activities have paved the way for business expansion and increased the customer base of market players. The players in the home infusion therapy market are anticipated to experience lucrative growth opportunities with the rising demand for home infusion therapy. The list of a few companies engaged in the home infusion therapy market is mentioned below:

• B. Braun Melsungen AG
• Optum, Inc.
• Baxter
• Nipro Corporation
• BD
• Fresenius Kabi AG
• ICU Medical, Inc.
• JMS Co. Ltd.
• Smiths Medical
• Terumo Corporation.

The report includes key profiles of companies operating in the home infusion therapy market, their SWOT analysis, and market strategies. It also focuses on leading industry players with information such as components and services offered, financial information for the last three years, and key development in the past five years.

The Insight Partner's dedicated research and analysis team comprises experienced professionals with advanced statistical expertise and offers various customization options in the current study.

Get more information on this report : Request Free Sample PDF